NCT01535235
ACE Inhibitors to Decrease Lymphoid Fibrosis in Antiretroviral-Treated, HIV-infected Patients: A Pilot Study
See it on ClinicalTrials.gov ↗31 people
100%
0 womenmiddle line = equal numbers31 men
- Phase
- PHASE4
- Paid for by
- University of California, San Francisco
- Finished
- 2014-12
- Health conditions
- HIV
- Who could join
- Anyone
- Ages
- 18 Years – no maximum
- Average age
- median 54 years
- Age 65+
- 0%
- Weight (BMI)
- Not reported
- Pregnancy recorded
- Not reported
- Menopause recorded
- Not reported
- Results shown by sex
- Not split by sex
- Race
- White 74.2% · Black / African American 9.7% · Hispanic / Latina 9.7% · Asian 3.2% · Native Hawaiian / Pacific Islander 3.2%
Women left out
- No pregnant women
Women who were pregnant could not join.
“Pregnant/breastfeeding women.”
- No breastfeeding moms
Women who were breastfeeding could not join.
“Pregnant/breastfeeding women.”
- No diabetes
Women with diabetes were turned away.
“Known diabetes mellitus or cardiovascular/kidney/collagen vascular disease”
Study titles and rules are shown in their original English.